Internal Medicine, Infectious Disease · Murrieta, CA
NPI
1396842704
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
28078 Baxter Rd, 320
Murrieta, CA, 92563
Phone (951) 679-5811
Groups this clinician bills Medicare through
Medicare paid, 2024
$138K
19,574 services
Medicare patients, 2024
415
Average age 73
Drug cost, 2024
$1.9M
768 prescriptions
Company payments, 2025
$21K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thuan Le was code 99233 (hospital e&m - subsequent), 494 times for 190 patients. In total Thuan Le billed 19,574 services in 24 codes, and Medicare paid $138K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 494 | 190 | $89.19 | $44K |
| 99214 Office E&M - Established | Office | 393 | 127 | $89.45 | $35K |
| 99223 Hospital E&M - Initial | Facility | 255 | 229 | $130.00 | $33K |
| 99204 Office E&M - New | Office | 49 | 49 | $129.40 | $6,340 |
| 99213 Office E&M - Established | Office | 43 | 33 | $70.42 | $3,028 |
| 99212 Office E&M - Established | Office | 12 | 11 | $44.39 | $533 |
By year: 2022 $315K for 290,949 services; 2023 $264K for 260,243 services; 2024 $138K for 19,574 services.
Medicare prescription drug claims, 2024
In 2024, the drug Thuan Le prescribed most often to Medicare patients was Nuzyra (Omadacycline Tosylate), with 48 prescriptions and refills. In total Thuan Le wrote 768 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Nuzyra Omadacycline Tosylate | 48 | 48 | Under 11 | $481K |
| Rifampin Generic | 44 | 46 | Under 11 | $2,337 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 43 | 43 | Under 11 | $171K |
| Juluca Dolutegravir/Rilpivirine | 39 | 71 | Under 11 | $242K |
| Ciprofloxacin Hcl Generic | 37 | 37 | 15 | $285 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 32 | 40 | 21 | $408 |
| Vancomycin Hcl Generic | 29 | 29 | Under 11 | $3,402 |
| Azithromycin Generic | 28 | 30 | Under 11 | $755 |
| Cabenuva Cabotegravir/Rilpivirine | 28 | 50 | Under 11 | $179K |
| Ethambutol Hcl Generic | 25 | 33 | Under 11 | $1,503 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 25 | 17 | $180 |
| Cefepime Hcl Generic | 25 | 25 | Under 11 | $4,114 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 24 | 24 | Under 11 | $354K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 24 | 24 | Under 11 | $95K |
| Clarithromycin Generic | 21 | 21 | Under 11 | $1,818 |
Brand drugs: 275 claims; generic drugs: 493 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thuan Le $21K ($21K in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 50 | $19K |
| ViiV Healthcare Company GSK | 41 | $1,222 |
| Cumberland Pharmaceuticals, Inc. CPIX | 2 | $518 |
| Insmed, Inc. INSM | 18 | $257 |
| Gilead Sciences, Inc. GILD | 6 | $156 |
| Paratek Pharmaceuticals, Inc. | 4 | $122 |
| La Jolla Pharmaceutical Company | 4 | $86.59 |
| Theratechnologies Inc. THTX | 3 | $78.69 |
| Merck Sharp & Dohme LLC MRK | 2 | $64.7 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $46.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.